Bioengineering (Focus Group – BE)

(115) Membrane dynamics modulate the functional activity of biomimetic nanoparticles

(116) Exploiting Metabolite-Presenting Molecules for Targeted Therapies

(117) Efficient and controlled drug release from PEDOT synthesised via surface-tethered dopant templating

(118) Biomimetic RBC-Liposomes: Impact of Membrane Properties on Protein Corona and Stability

(119) Unveiling the Role of Lipid Composition on Stability and Fusion of Biomimetic Liposomes

(120) Cluster differentiation-modified liposomes for lung targeted anti-inflammatory therapy

(121) Synthesis of exosome-mimicking exosomal nanoparticles using a microfluidic chip

(122) Bioinspired lipoprotein-mimetic nanocarriers: Tackling drug solubility and permeability challenges

(123) Endoplasmic reticulum stress-based approach for reprogramming tumor-derived exosome

(124) Microfluidic Fabrication of Alginate-PEGDGE Hydrogel Microspheres for Drug Delivery and Cell Therapy

(125) Macrophage-Mediated Delivery of Focused Ultrasound-Activated Nanocarriers for Triggered Drug Release

(126) Novel Intravenous Anticoagulant: Development and Testing for Safe, Effective Thrombosis Prevention

(127) Interactions of biomimetic liposomes with enterocytes explored by 3D Raman imaging

(128) Development of a microfluidic chip for efficient lipid formulation discovery of lipid nanoparticles

(129) Engineering Metal-Organic Framework-biopolymer-based Hydrogels for Controlled Therapeutic Delivery

(130) Development of TransMIT, nanocapsules for mitochondria-mediated cell function modulation

(131) Development of a solid-phase synthetic approach for triazine-based lipids

(132) Multimodal evaluation of a porous HA/β-TCP scaffold for bone repair and localized therapy in rats.

(133) Anticancer activity of extended release loperamide from styrene-isoprene-styrene polymer in vitro

(134) Cryoshocked T Lymphocytes (CSTLs) for Enhanced Delivery of Chemotherapeutics to the Lymph Node

(135) Responsive Silk Protein Plastics for Controlled Drug Release

(136) Biomimetic Multilayered Lipid Nanovesicle Vaccine Targeting Staphylococcus aureus α-Hemolysin

(137) Dendritic particles with nanostructured tendrils for adhesion and drug release to bladder cancers

(138) Kidnapper SA-Biosomes for alveolar macrophages targeting for managing pulmonary inflammation.

(139) Rheology-driven development of bioinks for advanced 3D-bioprinting in drug discovery

(140) Mesenchymal stem cells as gene delivering vehicles for activating prodrug around tumor cells

(141) Ultrasonic stimulation in a 3D HA hydrogel accelerates cellular reprogramming for iPS generation